A New Expert View on TIM Technology for Oral Drug Development
A new expert review in *Molecular Pharmaceutics* examines the application of the TIM (TNO Gastro-Intestinal Model) technology in the development of oral drug products. This advanced in vitro system simulates human gastrointestinal conditions, providing a sophisticated tool for predicting drug dissolution, release, and absorption. The article offers a critical analysis of how this technology can streamline formulation development, reduce reliance on early-stage clinical trials, and improve the accuracy of forecasting oral drug performance, which is crucial for optimizing bioavailability and therapeutic efficacy.
Study Significance: For anesthesiologists and pharmacologists, this review is highly relevant to the development of new oral anesthetic agents and perioperative medications. Understanding and utilizing predictive tools like TIM technology can accelerate the formulation of drugs with more reliable pharmacokinetic profiles, directly impacting premedication and postoperative pain management strategies. This represents a tangible advance in translational pharmacology, moving the field toward more efficient and evidence-based drug development pipelines.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
